Betaine Addition to Water Loading Prior to Running Exercise
Effects of a Betaine-Supplemented Hydration Protocol on Sweat Rate and Exercise Performance in Runners
This randomized, double-blind, placebo-controlled crossover study will investigate whether acute betaine ingestion as part of a pre-exercise hyperhydration strategy improves endurance running performance and influences hydration-related responses during prolonged exercise.
Approximately 30 recreationally trained male and premenopausal female runners will complete two experimental trials: a betaine condition and a placebo/control condition. In the betaine condition, participants will ingest anhydrous betaine at a dose of 0.07 g/kg body mass as part of a standardized pre-exercise hydration protocol providing a total fluid intake of approximately 25 mL/kg body mass.
Following the hydration protocol, participants will complete 60 minutes of treadmill running at 60% of the running velocity corresponding to VO₂max, followed by a 5-minute recovery period and a 5-km treadmill time trial.
The primary outcome will be 5-km running time-trial performance. Secondary outcomes will include exercise-induced fluid and sweat loss, urinary hydration markers, sweat electrolyte concentrations, physiological responses, exercise economy, substrate utilization, blood lactate concentration, perceived exertion, thirst, and thermal sensation.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Emilia Zawieja
- Número de teléfono: +48500415726
- Correo electrónico: emilia.zawieja@up.poznan.pl
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age 18-45 years
- Sex: men and premenopausal women
- Continuous running training for at least 12 months
- At least 3 running training sessions per week
- Willingness and ability to complete the treadmill exercise protocol: 60 minutes of running at 60% of the running velocity corresponding to VO₂max, followed by a 5-km running time trial
- Medical clearance for participation in maximal and prolonged exercise testing
Exclusion Criteria:
- Age <18 or >45 years
- Postmenopausal women
- Use of betaine, choline, folic acid/folate, or vitamin B12 supplements within 3 months prior to study participation
- Current musculoskeletal injury or injury occurring within the previous 2 months
- Uncontrolled arterial hypertension
- Pregnancy or breastfeeding
- Diabetes requiring insulin therapy or inadequately controlled diabetes
- Active or severe liver disease, including ALT or AST >3× the upper limit of normal
- Renal impairment, including eGFR <60 mL/min/1.73 m²
- Untreated or unstable thyroid disease, including hypothyroidism or hyperthyroidism
- Gastrointestinal disease that may affect nutrient absorption
- Kidney disease, cardiovascular disease, irritable bowel syndrome, or adrenal disease
- Use of diuretics, SGLT2 inhibitors, laxatives, or glucocorticoids
- Any medical contraindication to physical exercise and/or failure to obtain medical clearance for exercise testing
- Elevated body temperature at the time of testing
- Cystic fibrosis
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Triple
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Betaine → Placebo Sequence
Participants will first complete the betaine-enriched hyperhydration condition. After the washout period, they will complete the placebo hyperhydration condition. |
Anhydrous betaine (trimethylglycine) will be administered as a single dose of 0.07 g/kg body mass, dissolved in a commercially available sports drink (5 mL/kg body mass), 150 minutes before exercise. The betaine-containing drink will constitute the first bolus of a standardized pre-exercise hyperhydration protocol providing a total fluid intake of approximately 25 mL/kg body mass over 120 minutes. Participants will receive the same commercially available sports drink (5 mL/kg body mass) without added betaine 150 minutes before exercise. This will be followed by four additional fluid boluses of mineral water (5 mL/kg each) administered at 120, 90, 60, and 30 minutes before exercise, for a total pre-exercise fluid intake of approximately 25 mL/kg body mass. |
|
Experimental: Placebo → Betaine Sequence
Participants will first complete the placebo hyperhydration condition. After the washout period, they will complete the betaine-enriched hyperhydration condition. |
Anhydrous betaine (trimethylglycine) will be administered as a single dose of 0.07 g/kg body mass, dissolved in a commercially available sports drink (5 mL/kg body mass), 150 minutes before exercise. The betaine-containing drink will constitute the first bolus of a standardized pre-exercise hyperhydration protocol providing a total fluid intake of approximately 25 mL/kg body mass over 120 minutes. Participants will receive the same commercially available sports drink (5 mL/kg body mass) without added betaine 150 minutes before exercise. This will be followed by four additional fluid boluses of mineral water (5 mL/kg each) administered at 120, 90, 60, and 30 minutes before exercise, for a total pre-exercise fluid intake of approximately 25 mL/kg body mass. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
5-km Running Time-Trial Performance
Periodo de tiempo: During the 5-km treadmill time trial performed after the 60-minute running preload and a 5-minute recovery period in each experimental trial.
|
Time required to complete a 5-km treadmill running time trial, expressed in seconds. Participants will be instructed to complete the distance as quickly as possible and will be allowed to adjust treadmill speed throughout the trial. Lower completion time indicates better performance. |
During the 5-km treadmill time trial performed after the 60-minute running preload and a 5-minute recovery period in each experimental trial.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sweat rate
Periodo de tiempo: From immediately before the 60-minute running preload to completion of the subsequent 5-km time trial during each experimental trial.
|
Whole-body sweat rate will be estimated from the change in body mass from immediately before exercise to completion of the 5-km time trial, adjusted for fluid intake and urine output, if applicable, and expressed as L/h. Body mass will be measured using the calibrated electronic scale integrated with the BOD POD system (COSMED, Italy) and expressed in kilograms (kg). Changes in body mass will also be calculated and reported as a percentage of pre-exercise body mass (%). |
From immediately before the 60-minute running preload to completion of the subsequent 5-km time trial during each experimental trial.
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sweat sodium concentration
Periodo de tiempo: Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.
|
Sodium concentration will be measured in sweat samples collected from standardized sites on the forearm and thigh during exercise. Sweat samples will be collected between minutes 30 and 60 of the 60-minute running preload. Sodium concentration will be analyzed using a HORIBA ion-selective electrode analyzer and reported in mmol/L. |
Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.
|
|
Sweat Potassium Concentration
Periodo de tiempo: Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.
|
Potassium concentration will be measured in sweat samples collected from standardized sites on the forearm and thigh during exercise. Sweat samples will be collected between minutes 30 and 60 of the 60-minute running preload. Sweat potassium concentration will be analyzed using a HORIBA ion-selective electrode analyzer and reported in mmol/L. |
Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.
|
|
Blood lactate concentration
Periodo de tiempo: Immediately after the 60-minute running preload and immediately after the 5-km time trial during each experimental trial.
|
Blood lactate concentration will be measured using a portable Lactate Scout 4 analyzer. Measurements will be obtained immediately after completion of the 60-minute running preload and immediately after completion of the subsequent 5-km time trial. Blood lactate concentration will be reported in mmol/L. |
Immediately after the 60-minute running preload and immediately after the 5-km time trial during each experimental trial.
|
|
Heart rate
Periodo de tiempo: Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.
|
Heart rate will be monitored continuously using a Garmin chest-strap heart rate monitor with integrated electrodes throughout the 60-minute running preload and the subsequent 5-km time trial. Outcome variables will include mean heart rate during the 60-minute preload, mean heart rate during the 5-km time trial, and maximal heart rate achieved during the 5-km time trial. Heart rate will be reported in beats per minute (bpm). |
Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.
|
|
Core Body Temperature
Periodo de tiempo: Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.
|
Core body temperature will be monitored continuously using a CORE body temperature sensor attached to the Garmin chest strap throughout the 60-minute running preload and the subsequent 5-km time trial. Outcome variables will include mean core body temperature during the exercise protocol and the highest core body temperature recorded during the exercise protocol. Temperature will be reported in degrees Celsius (°C). |
Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.
|
|
Running Economy
Periodo de tiempo: During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.
|
Running economy will be assessed by breath-by-breath indirect calorimetry using a QUARK RMR metabolic system during the final 10 minutes (minutes 50-60) of the 60-minute running preload. Running economy will be quantified as mean oxygen consumption (VO₂) relative to body mass at the standardized running velocity and expressed as mL·kg-¹·min-¹. Lower oxygen consumption at the same running velocity indicates better running economy. |
During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.
|
|
Respiratory Exchange Ratio
Periodo de tiempo: During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.
|
Respiratory exchange ratio (RER) will be assessed by breath-by-breath indirect calorimetry using a QUARK RMR metabolic system during the final 10 minutes (minutes 50-60) of the 60-minute running preload. RER will be calculated as the ratio of carbon dioxide production (VCO₂) to oxygen consumption (VO₂) and expressed as a unitless value. The mean RER over the measurement period will be used for analysis. |
During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.
|
|
Urine specific gravity
Periodo de tiempo: Immediately before the 60-minute running preload and immediately after completion of the 5-km time trial in each experimental trial.
|
Urine specific gravity (USG) will be measured using a URIT-31 urine analyzer from urine samples collected immediately before the 60-minute running preload and after completion of the subsequent 5-km time trial. USG will be reported as a dimensionless value. Urine osmolality will also be estimated from USG using a predefined conversion equation and reported in mOsm/kg. |
Immediately before the 60-minute running preload and immediately after completion of the 5-km time trial in each experimental trial.
|
|
Rating of Perceived Exertion (RPE)
Periodo de tiempo: At minutes 30, and 60 of the 60-minute running preload and immediately after completion of the 5-km time trial during each experimental trial.
|
Rating of perceived exertion will be assessed using the Borg 6-20 Rating of Perceived Exertion scale, ranging from 6 ("no exertion at all") to 20 ("maximal exertion"). RPE will be recorded at 15-minute intervals during the 60-minute running preload and immediately after completion of the 5-km time trial. |
At minutes 30, and 60 of the 60-minute running preload and immediately after completion of the 5-km time trial during each experimental trial.
|
|
Thirst Sensation
Periodo de tiempo: Immediately before the 60-minute running preload, at minutes 30,and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.
|
Perceived thirst will be assessed using a 9-point categorical thirst sensation scale ranging from 1 ("not thirsty at all") to 9 ("very, very thirsty"). Participants will be asked to rate their current sensation of thirst at each measurement time point. |
Immediately before the 60-minute running preload, at minutes 30,and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.
|
|
Thermal Sensation
Periodo de tiempo: Immediately before the 60-minute running preload, at minutes 30 and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.
|
Thermal sensation will be assessed using a 17-point thermal sensation scale ranging from 0 to 8 in 0.5-point increments, with 0 representing "unbearably cold", 4 representing "neutral", and 8 representing "unbearably hot". Participants will rate their whole-body thermal sensation at each measurement time point. |
Immediately before the 60-minute running preload, at minutes 30 and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- BETxSWEAT
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .